Sunday , July 22 2018
Home / David L. Joffe, BSPharm, CDE, FACA (page 21)

David L. Joffe, BSPharm, CDE, FACA

David L. Joffe, BSPharm, CDE, FACA
(Editor-in-Chief Diabetes In Control) A graduate of University of Kentucky College of Pharmacy, he has practiced in the Tampa Bay area since 1986, has been providing diabetes and cardiovascular care in Tampa Bay since 1995, and spent 2 years as an Eckerd Patient Care Pharmacist managing over 100 diabetes patients. Dave currently sees patients in over 30 primary care and endocrinologists offices.

Oct. 8, 2016

This week the take home message asks us to change from “start low and go slow,” to “be aggressive not repressive.” More and more documentation shows the value of adding newer classes of medications sooner to get our patients to target. Part of this comes from the sheer acknowledgement that …

Read More »

Oct. 4, 2016

There are often times when I don’t know which of the features to select to comment on in the Editor’s Desk. This week is one of those weeks. The topics are diverse, and it is hard to see every subject appealing to every reader. If you are a science person, …

Read More »

Oct. 1, 2016

Most of you know that I love to cycle, and many times we bring you information on Team NovoNordisk and how they are doing in the professional cycling world. It is sad to say most of our patients would be hard pressed to get on a bike, much less ride …

Read More »

Sept. 27, 2016

This past weekend I attended a CE for medical directors, nursing home administrators and pharmacists. There was a lot of great information focused on taking care of the whole patient. The take-home message resounds in the Homerun Slides we have for you this week. These slides give you the basis …

Read More »

Sept. 24, 2016

The standard treatment for uncontrolled uterine bleeding has been emergency care where a woman undergoes transfusion dilatation curettage and then a hysterectomy. This is a severe procedure with a long recovery time and long-lasting complications. Over the past few years, a lot of women have been treated with endometrialhydrothermal ablation, a much less invasive procedure with …

Read More »

Sept. 22, 2016

For years many of us have lamented the butchering that Dr. Steven Nissen gave to the TZDs. Part of this came from the extra cardiovascular studies that every manufacturer had to do on new diabetes drugs that came to market. Many of you thought that those studies were useless and …

Read More »

Sept. 20, 2016

This past weekend, I presented a talk to Consultant Pharmacists, Directors of Nursing, and Medical Directors in Long Term Care. We were focusing on the team approach to diabetes care and how that has changed over the past couple of years. (Part of that presentation is in this week’s Homerun …

Read More »